Figure 8. AFP immunization synergizes with anti–PD-L1 administration to inhibit cMet/β-catenin–induced HCC progression.

(A) Study design. (B) Survival curve of the various groups tested. (C) Representative liver gross images and HE results (original magnification: 100 ×) of the investigated groups from B, the numbers indicate the liver weight and weeks from injection to sacrifice date for that particular mouse. Kaplan-Meier test was used for survival analysis in B. **P < 0.01, ***P < 0.001. W, week(s); Comb, combination therapy; Immu, immunization.